Tag Archives: EQT Life Sciences

Novo Nordisk Acquires Cardior Pharmaceuticals in Billion-Euro Deal, Pioneering RNA Therapies for Heart Diseases

(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk’s acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to EUR 1.025 billion. Based in Hannover, Germany, Cardior specializes in RNA-based therapeutics for cardiovascular diseases, focusing initially on heart failure. … Read the full press release

EQT Life Sciences Portfolio Company Amolyt Pharma Acquired by Alexion, AstraZeneca Rare Diseases for $1.05 Billion

(IN BRIEF) EQT Life Sciences announces the acquisition of its portfolio company, Amolyt Pharma, by Alexion, AstraZeneca Rare Diseases, for a total deal value of $1.05 billion. This acquisition underscores Amolyt’s significant advancements in developing novel treatments for rare endocrine … Read the full press release

Tubulis Secures €128 Million Series B2 Financing to Advance Novel ADC Pipeline for Cancer Treatment

(IN BRIEF) Tubulis has closed an oversubscribed €128 million ($138.8 million) Series B2 financing round, co-led by EQT Life Sciences and Nextech Invest Ltd, with participation from new and existing investors including Frazier Life Sciences and Deep Track Capital. The … Read the full press release

Phagenesis Secures $42M Investment Led by EQT Life Sciences to Revolutionize Swallowing Disorder Treatment

(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series D financing round led by EQT Life Sciences, with co-leadership from Sectoral Asset Management. This substantial investment reflects confidence in … Read the full press release

EQT Life Sciences and Gimv Lead €30M Series C Round for Onera Health to Advance Sleep Diagnostics

(IN BRIEF) Onera Health, a leader in sleep diagnostic and monitoring solutions, has successfully completed a €30 million ($32 million) Series C financing round. The funding was led by EQT Life Sciences and co-led by Gimv, with participation from existing … Read the full press release

EQT gründet nach der Übernahme von LSP eine neue Geschäftseinheit innerhalb seines Private Capital-Geschäftssegments

(PRESSEMITTEILUNG) STOCKHOLM, 1-Mar-2022 — /EuropaWire/ — EQT, eine zweckorientierte globale Investmentorganisation, hat die Gründung eines neu gegründeten Unternehmens bekannt gegeben Geschäftsbereich innerhalb seines Private Capital-Geschäftssegments mit dem Namen EQT Life Sciences. Die Gründung des neuen Unternehmens folgt auf den Abschluss … Read the full press release

EQT establishes a new business unit within its Private Capital business segment following the acquisition of LSP

(PRESS RELEASE) STOCKHOLM, 1-Mar-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced the establishment of a newly formed business line within its Private Capital business segment called EQT Life Sciences. The formation of the new entity follows … Read the full press release

EQT AB to acquire European life sciences venture capital firm Life Sciences Partners

LSP will strengthen EQT’s position as one of the leading and most active private markets investors in the healthcare sector. LSP’s highly experienced team will complement EQT’s existing knowledge base within life sciences and expand EQT’s ability to support companies … Read the full press release